Table 4.

The association between urea reduction with KRT or C and 10-day mortality

	Model 1a		Model 2b
	OR (95% CI)	p value	OR (95% CI)	p value
>50% C	1 (reference)	–	1 (reference)	–
>50% KRT	0.84 (0.73–0.97)	0.01	0.95 (0.81–1.11)	0.57
26–50% C	0.86 (0.78–0.95)	0.004	1.01 (0.88–1.15)	0.84
26–50% KRT	0.93 (0.81–1.08)	0.38	1.06 (0.90–1.24)	0.44
1–25% C	0.88 (0.81–0.96)	0.006	1.04 (0.92–1.18)	0.49
1–25% KRT	1.15 (1.02–1.30)	0.01	1.20 (1.04–1.39)	0.009
0% C	1.10 (1.03–1.17)	0.001	1.15 (1.03–1.28)	0.009
0% KRT	1.38 (1.27–1.49)	<0.001	1.42 (1.26–1.28)	<0.001

^aModel 1: unadjusted.

^bModel 2: adjusted for age, sex, gender, diabetes mellitus, chronic kidney disease, antibiotics, sepsis, hypovolemia, cardio-renal syndrome, shock, and AKI stage.

KRT, kidney replacement therapy; C, conservative treatment.